Mutations in the PSEN1 and PSEN2 genes encoding Presenilin-1 (PS1) and Presenilin-2 (PS2) are the most common cause of familial Alzheimer's disease (FAD), highlighting the importance of Presenilin function in disease pathogenesis, but the underlying mechanisms remain unresolved. Aberrant APP processing by ?- secretase and ?-secretase-independent activities of PS1 have been implicated in FAD pathogenesis. Our recent work has shown surprisingly that pathogenic mutations in PS1 can inactivate its function as the catalytic subunit of the ?-secretase complex and produce FAD-related phenotypes through a loss-of-function mechanism. To assess the effects of FAD mutations in vivo, particularly in the brain where the pathogenic process occurs, we generated two independent lines of Psen1 knock-in (KI) mice that precisely reproduce chromosomal PSEN1 mutations identified in FAD patients. Our analysis revealed phenotypes in the resulting homozygous KI mice indistinguishable from those caused by a Psen1 null mutation, accompanied by essentially complete loss of ?-secretase activity in the brain. Heterozygosity for the Psen1 L435F KI mutation produced deficits in hippocampal short- and long-term synaptic plasticity and hippocampal learning and memory reminiscent of those caused by conditional inactivation of Presenilins in the adult brain. Intriguingly, heterozygous KI mice also displayed elevation of the cortical A?42/A?40 ratio and exacerbation of cortical A? deposition on a mutant APP transgenic background. Moreover, the Psen1 L435F KI mutation was unable to support neuronal survival in the aging brain, triggering widespread cerebral cortical neurodegeneration. In this competing renewal application, we propose to investigate the important questions of whether and to what extent these synaptic, behavioral, and neurodegenerative phenotypes caused by the FAD mutation are attributable to aberrant APP processing and impaired ?-secretase activity, or alternatively to APP-independent and/or ?-secretase-independent functions of PS1. We propose to perform multidisciplinary molecular, synaptic, behavioral, and histological analysis using novel mouse models to understand the contributions of APP processing and ?-secretase-independent activity to Presenilin function and FAD-related dysfunction in the adult brain. The results of our studies will have significant impact on understanding of FAD pathogenesis and strategies to devise effective therapies.

Public Health Relevance

Alzheimer's disease (AD) is the most common neurodegenerative disorder, and mutations in the Presenilin genes are the most common cause of inherited or familial AD (FAD). Results from our recent generation and multidisciplinary analysis of novel mouse models point to an important role for loss of Presenilin function in FAD pathogenesis. In this application, we propose to investigate the mechanisms by which Presenilin mutations impair synaptic function, learning and memory, and neuronal survival in the adult brain. Completion of these studies will advance efforts to understand FAD pathogenesis and devise effective therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS075346-07
Application #
9272013
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Corriveau, Roderick A
Project Start
2011-07-01
Project End
2021-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
7
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Kelleher 3rd, Raymond J; Shen, Jie (2017) Presenilin-1 mutations and Alzheimer's disease. Proc Natl Acad Sci U S A 114:629-631
Xia, Dan; Kelleher 3rd, Raymond J; Shen, Jie (2016) Loss of A?43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain. Neuron 90:417-22
Xia, Dan; Watanabe, Hirotaka; Wu, Bei et al. (2015) Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease. Neuron 85:967-81
Heilig, Elizabeth A; Gutti, Usha; Tai, Tara et al. (2013) Trans-dominant negative effects of pathogenic PSEN1 mutations on ?-secretase activity and A? production. J Neurosci 33:11606-17
Watanabe, Hirotaka; Xia, Dan; Kanekiyo, Takahisa et al. (2012) Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice. J Neurosci 32:5085-96
Anguera, Montserrat C; Ma, Weiyuan; Clift, Danielle et al. (2011) Tsx produces a long noncoding RNA and has general functions in the germline, stem cells, and brain. PLoS Genet 7:e1002248
Wines-Samuelson, Mary; Schulte, Eva C; Smith, Miriam J et al. (2010) Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice. PLoS One 5:e10195
Kelleher 3rd, Raymond J; Shen, Jie (2010) Genetics. Gamma-secretase and human disease. Science 330:1055-6
Heilig, Elizabeth A; Xia, Weiming; Shen, Jie et al. (2010) A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem 285:22350-9